DRREDDY:NSE
Dr Reddy's Laboratories Ltd
₹1.349,50
arrow_upward
+1,59%(+21,10) 1G
25 Haz, 15:30:00 GMT+5:30 · INR
search
Tüm semboller
1G
5G
1A
6A
Yıl Başından Beri
1Y
5Y
MAKS
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoDRREDDY ile ilgili en önemli analizler oluşturuluyor...
Açık
₹1.331,90
Yüksek
₹1.363,00
Düşük
₹1.331,90
Piy. değ.
1,12 Tn
Ort. hacim
1,78 Mn
İşlem Hacmi
1,70 Mn
Kâr payı
%0,59
Üç aylık temettü
₹2,00
Temettüsüz işlem tarihi
10 Tem 2026
F/K oranı
26,80
52 haftalık en yüksek
₹1.375,90
52 haftalık en düşük
₹1.148,40
HBK
₹50,35
Tedavüldeki hisse senedi sayısı
166,06 Mn
Çalışan sayısı
28 B
Açık
₹1.331,90
Yüksek
₹1.363,00
Düşük
₹1.331,90
Piy. değ.
1,12 Tn
Ort. hacim
1,78 Mn
İşlem Hacmi
1,70 Mn
Kâr payı
%0,59
Üç aylık temettü
₹2,00
Temettüsüz işlem tarihi
10 Tem 2026
F/K oranı
26,80
52 haftalık en yüksek
₹1.375,90
52 haftalık en düşük
₹1.148,40
HBK
₹50,35
Tedavüldeki hisse senedi sayısı
166,06 Mn
Çalışan sayısı
28 B
Haberler
Web genelindeki kaynaklardan
TipRanks
·
2 gün önce
Dr. Reddy’s Gets Seven USFDA Observations After Biologics Plant Inspection
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Dr Reddy's Laboratories Ltd hakkında
CEOErez Israeli
Çalışan Sayısı27,5 B
Kuruluş Tarihi1984
Genel MerkezHaydarabad, Andra Pradeş, Hindistan
Sektör-
Web Sitesidrreddys.com
Yapay zeka içeriklerinde hata olabilir. Daha fazla bilgi